ArticleCureus2021

Relative Risk of Peripheral Neuropathy With Ado-Trastuzumab Emtansine (T-DM1) Compared to Taxane-Based Regimens in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Cancers: A Systematic Review and Meta-Analysis.

Nusrat Jahan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.